Recruiting Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs. NCT07165132 Conditions Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +24 more Locations Research Facility — Iowa City, Iowa, United States Research Facility — Lexington, Kentucky, United States Research Facility — St Louis, Missouri, United States Research Facility — St Louis, Missouri, United States View more locations Show fewer locations Loading locations... View Trial Details
Recruiting Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy NCT05477576 Conditions Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +22 more Locations Research Facility — Phoenix, Arizona, United States Research Facility — Duarte, California, United States Research Facility — Irvine, California, United States Research Facility — Los Angeles, California, United States View all 54 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Phase II Study of Ibrutinib in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors NCT02575300 Conditions Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +18 more Locations H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States View Trial Details
